Search
for
Sort by
Research 361–390 of 1000+
- PULSED ADMINISTRATION OF CORTICOSTEROIDS IN THE TREATMENT OF ALOPECIA AREATA
- Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double‐blind placebo‐controlled trial
- Gene Array Profiling and Immunomodulation Studies Define a Cell-Mediated Immune Response Underlying the Pathogenesis of Alopecia Areata in a Mouse Model and Humans
- Overview of Alopecia Areata
- Alopecia areata: Clinical presentation, diagnosis, and unusual cases
- Evaluation of Anthralin in the Treatment of Alopecia Areata
- Recent Advances in the Pathogenesis of Autoimmune Hair Loss Disease Alopecia Areata
- Vitamin D deficiency in alopecia areata
- PUVA treatment of alopecia areata partialis, totalis and universalis: audit of 10 years' experience at St John's Institute of Dermatology
- Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata
- Systemic Steroids With or Without 2% Topical Minoxidil in the Treatment of Alopecia Areata
- Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata
- Comorbidities in alopecia areata: A systematic review and meta-analysis
- Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injector
- A Comparison of the Efficacy, Relapse Rate and Side Effects among Three Modalities of Systemic Corticosteroid Therapy for Alopecia Areata
- Treatment of alopecia areata: An Australian expert consensus statement
- Health-related quality of life (HRQoL) among patients with alopecia areata (AA): A systematic review
- Onion Juice (Allium cepa L.), A New Topical Treatment for Alopecia Areata
- Alopecia Areata: An Updated Review for 2023
- Cytokines and growth factors influence hair growth in vitro. Possible implications for the pathogenesis and treatment of alopecia areata
- Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata
- THE PATHOGENESIS OF ALOPECIA AREATA
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
- Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia
- Role of the Autoimmune Regulator (<i>AIRE</i>) gene in alopecia areata: Strong association of a potentially functional <i>AIRE</i> polymorphism with alopecia universalis
- 308-nm excimer laser therapy in alopecia areata
- Alopecia areata in children:, response to treatment with diphencyprone
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies